Natural scientific research in Canada Queen's/Hotel Dieu Hospital, Kingston, 1845, U of T/Hospital for Sick Children, Toronto, 1875, UBC/Vancouver General Hospital, 1886, Dalhousie/Victoria General Hospital, Halifax, 1887 and the U of A/ the University of Alberta Hospital, Edmonton, 1906. The Connaught Laboratories in Toronto conducted groundbreaking research in the fifties with respect to the world's first polio vaccine. Working with Dr. Jonas Salk in the US, the laboratories developed a safe inactive vaccine using a new synthetic base, Medium 199. This permitted large volume production through a technique that came to be known as the "Toronto Method", which in turn allowed the mass vaccination campaigns
Remune P < 0.05 & HIV-1 lymphocyte proliferation P < 0.001 both favoring the Remune Group. The International AIDS Vaccine Research (IAVA) issued a report on “Whole Killed AIDS Vaccines” in 1999 reviewing a diverse aspect of the killed virus approach. Remune Remune is the first therapeutic HIV vaccine based on the killed whole virus approach. Remune was initially invented by Jonas Salk in 1987 and is now being developed by Immune Response BioPharma, Inc. (IRBP) Remune is a therapeutic HIV/AIDS vaccine that has completed over 25 clinical studies to date and shows a robust mechanism of action restoring white blood